{
    "id": 23643,
    "fullName": "MAP2K2 Q60P",
    "impact": "missense",
    "proteinEffect": "gain of function",
    "geneVariantDescriptions": [
        {
            "description": "MAP2K2 Q60P does not lie within any known functional domains of the Map2k2 protein (UniProt.org). Q60P results in activation of Map2k2 and increased ERK1/2 phosphorylation in cell culture and is associated with resistance to RAF and MEK inhibitors (PMID: 24265154, PMID: 24055054).",
            "references": [
                {
                    "id": 6042,
                    "pubMedId": 24055054,
                    "title": "Concurrent MEK2 mutation and BRAF amplification confer resistance to BRAF and MEK inhibitors in melanoma.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/24055054"
                },
                {
                    "id": 295,
                    "pubMedId": null,
                    "title": null,
                    "url": "https://www.uniprot.org"
                },
                {
                    "id": 6036,
                    "pubMedId": 24265154,
                    "title": "MAP kinase pathway alterations in BRAF-mutant melanoma patients with acquired resistance to combined RAF/MEK inhibition.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/24265154"
                }
            ]
        }
    ],
    "type": null,
    "gene": {
        "id": 5605,
        "geneSymbol": "MAP2K2",
        "terms": [
            "MAP2K2",
            "CFC4",
            "MAPKK2",
            "MEK2",
            "MKK2",
            "PRKMK2"
        ]
    },
    "variant": "Q60P",
    "createDate": "06/23/2016",
    "updateDate": "07/01/2018",
    "referenceTranscriptCoordinates": {
        "id": 158810,
        "transcript": "NM_030662",
        "gDna": "chr19:g.4117543T>G",
        "cDna": "c.179A>C",
        "protein": "p.Q60P",
        "sourceDb": "RefSeq",
        "refGenomeBuild": "GRCh38/hg38"
    },
    "partnerGenes": [
        
    ],
    "evidence": [
        {
            "id": 7019,
            "approvalStatus": "Preclinical",
            "evidenceType": "Actionable",
            "efficacyEvidence": "In a preclinical study, MAP2K2 Q60P conferred resistance to Mekinist (trametinib) in BRAF V600E-mutant melanoma cells in culture (PMID: 24265154).",
            "molecularProfile": {
                "id": 24360,
                "profileName": "BRAF V600E MAP2K2 Q60P"
            },
            "therapy": {
                "id": 2,
                "therapyName": "Trametinib",
                "synonyms": null
            },
            "indication": {
                "id": 1909,
                "name": "melanoma",
                "source": "DOID"
            },
            "responseType": "resistant",
            "references": [
                {
                    "id": 6036,
                    "pubMedId": 24265154,
                    "title": "MAP kinase pathway alterations in BRAF-mutant melanoma patients with acquired resistance to combined RAF/MEK inhibition.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/24265154"
                }
            ],
            "ampCapAscoEvidenceLevel": "D",
            "ampCapAscoInferredTier": "II"
        },
        {
            "id": 7017,
            "approvalStatus": "Preclinical",
            "evidenceType": "Actionable",
            "efficacyEvidence": "In a preclinical study, MAP2K2 Q60P conferred resistance to Tafinlar (dabrafenib) in BRAF V600E-mutant melanoma cells in culture (PMID: 24265154).",
            "molecularProfile": {
                "id": 24360,
                "profileName": "BRAF V600E MAP2K2 Q60P"
            },
            "therapy": {
                "id": 3,
                "therapyName": "Dabrafenib",
                "synonyms": null
            },
            "indication": {
                "id": 1909,
                "name": "melanoma",
                "source": "DOID"
            },
            "responseType": "resistant",
            "references": [
                {
                    "id": 6036,
                    "pubMedId": 24265154,
                    "title": "MAP kinase pathway alterations in BRAF-mutant melanoma patients with acquired resistance to combined RAF/MEK inhibition.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/24265154"
                }
            ],
            "ampCapAscoEvidenceLevel": "D",
            "ampCapAscoInferredTier": "II"
        },
        {
            "id": 7020,
            "approvalStatus": "Preclinical",
            "evidenceType": "Actionable",
            "efficacyEvidence": "In a preclinical study, MAP2K2 Q60P conferred resistance to the combination of Tafinlar (dabrafenib) and Mekinist (trametinib) in BRAF V600E-mutant melanoma cells in culture (PMID: 24265154).",
            "molecularProfile": {
                "id": 24360,
                "profileName": "BRAF V600E MAP2K2 Q60P"
            },
            "therapy": {
                "id": 1066,
                "therapyName": "Dabrafenib + Trametinib",
                "synonyms": null
            },
            "indication": {
                "id": 1909,
                "name": "melanoma",
                "source": "DOID"
            },
            "responseType": "resistant",
            "references": [
                {
                    "id": 6036,
                    "pubMedId": 24265154,
                    "title": "MAP kinase pathway alterations in BRAF-mutant melanoma patients with acquired resistance to combined RAF/MEK inhibition.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/24265154"
                }
            ],
            "ampCapAscoEvidenceLevel": "D",
            "ampCapAscoInferredTier": "II"
        },
        {
            "id": 7014,
            "approvalStatus": "Preclinical",
            "evidenceType": "Actionable",
            "efficacyEvidence": "In a preclinical study, VX-11e inhibited growth of BRAF V600E-mutant melanoma cells expressing MAP2K2 Q60P in culture (PMID: 24265154).",
            "molecularProfile": {
                "id": 24360,
                "profileName": "BRAF V600E MAP2K2 Q60P"
            },
            "therapy": {
                "id": 2804,
                "therapyName": "VX-11e",
                "synonyms": null
            },
            "indication": {
                "id": 1909,
                "name": "melanoma",
                "source": "DOID"
            },
            "responseType": "sensitive",
            "references": [
                {
                    "id": 6036,
                    "pubMedId": 24265154,
                    "title": "MAP kinase pathway alterations in BRAF-mutant melanoma patients with acquired resistance to combined RAF/MEK inhibition.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/24265154"
                }
            ],
            "ampCapAscoEvidenceLevel": "D",
            "ampCapAscoInferredTier": "II"
        }
    ],
    "molecularProfiles": [
        {
            "id": 24349,
            "profileName": "MAP2K2 Q60P",
            "profileTreatmentApproaches": [
                
            ]
        },
        {
            "id": 24360,
            "profileName": "BRAF V600E MAP2K2 Q60P",
            "profileTreatmentApproaches": [
                
            ]
        }
    ],
    "allTranscriptCoordinates": [
        {
            "id": 158809,
            "transcript": "XM_006722799",
            "gDna": "chr19:g.4117543T>G",
            "cDna": "c.179A>C",
            "protein": "p.Q60P",
            "sourceDb": "RefSeq",
            "refGenomeBuild": "GRCh38/hg38"
        },
        {
            "id": 158813,
            "transcript": "XM_017026991",
            "gDna": "chr19:g.4117543T>G",
            "cDna": "c.179A>C",
            "protein": "p.Q60P",
            "sourceDb": "RefSeq",
            "refGenomeBuild": "GRCh38/hg38"
        },
        {
            "id": 158810,
            "transcript": "NM_030662",
            "gDna": "chr19:g.4117543T>G",
            "cDna": "c.179A>C",
            "protein": "p.Q60P",
            "sourceDb": "RefSeq",
            "refGenomeBuild": "GRCh38/hg38"
        },
        {
            "id": 158811,
            "transcript": "XM_017026990",
            "gDna": "chr19:g.4117543T>G",
            "cDna": "c.179A>C",
            "protein": "p.Q60P",
            "sourceDb": "RefSeq",
            "refGenomeBuild": "GRCh38/hg38"
        },
        {
            "id": 158812,
            "transcript": "XM_017026989",
            "gDna": "chr19:g.4117543T>G",
            "cDna": "c.179A>C",
            "protein": "p.Q60P",
            "sourceDb": "RefSeq",
            "refGenomeBuild": "GRCh38/hg38"
        }
    ]
}